Hopkins receives $35M to study cancer metastasis

Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-cell tumors.

April 05, 2024

Vol.50 No.14

Clinical Roundup

UC researchers identify novel protein that may help prevent breast cancer spread

University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan have identified a protein that helps prevent metastasis of HER2-positive breast cancer. About 20% of breast cancer patients are HER2-positive, and these cancers tend to be more aggressive than other types.

March 08, 2024

Vol.50 No.10

In Brief

Chi Van Dang to receive 2024 AACR-Margaret Foti Award

Chi Van Dang will receive the 2024 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research. The recognition will take place during this year’s AACR annual meeting, April 5-10 in San Diego, CA.

February 23, 2024

Vol.50 No.08

Clinical Roundup

Hopkins study: Immune cell receptor provides promising immunotherapy target

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients’ immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.

February 23, 2024

Vol.50 No.08

Clinical Roundup

Natural compounds derived from soy, plants reduce breast cancer recurrence, study shows

Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death, according to a meta-analysis co-directed by investigators from the Johns Hopkins Kimmel Cancer Center.

January 12, 2024

Vol.50 No.02

Clinical Roundup

Experimental drug combination shows promise against hard-to-treat peripheral nerve sheath tumors

Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies led by investigators at the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery.

December 01, 2023

Vol.49 No.44

Hopkins receives $35M to study cancer metastasis

YOU MAY BE INTERESTED IN

Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study

UC researchers identify novel protein that may help prevent breast cancer spread

Chi Van Dang to receive 2024 AACR-Margaret Foti Award

Hopkins study: Immune cell receptor provides promising immunotherapy target

Natural compounds derived from soy, plants reduce breast cancer recurrence, study shows

Experimental drug combination shows promise against hard-to-treat peripheral nerve sheath tumors

Renew today!

Subscriber content

Login